Cargando…
Outcomes of Patients with Malignancy Admitted to the Intensive Care Units: A Prospective Study
INTRODUCTION: Decisions regarding whether advanced cancer patients should be admitted to the ICU are based on a complex suite of considerations, including short- and long-term prognosis, quality of life, and therapeutic options to treat cancer. We aimed to describe demographic, clinical, and surviva...
Autores principales: | Assi, Hazem I., Halim, Nour Abdul, Alameh, Ibrahim, Khoury, Jessica, Nahra, Vicky, Sukhon, Fares, Charafeddine, Maya, El Nakib, Clara, Moukalled, Nour, Bou Zerdan, Maroun, Bou Khalil, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429029/ https://www.ncbi.nlm.nih.gov/pubmed/34513091 http://dx.doi.org/10.1155/2021/4792309 |
Ejemplares similares
-
Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021) -
Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients
por: Assi, Hazem I., et al.
Publicado: (2021) -
Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021) -
Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021) -
Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)